Sorrento Therapeutics, Inc. Annual Return On Equity in % from 2016 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Sorrento Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2016 to 2022.
  • Sorrento Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2023 was 1.01K %.
  • Sorrento Therapeutics, Inc. annual Return On Equity for 2022 was -487 %, a 77.9% decline from 2021.
  • Sorrento Therapeutics, Inc. annual Return On Equity for 2021 was -274 %, a 4.28% increase from 2020.
  • Sorrento Therapeutics, Inc. annual Return On Equity for 2020 was -286 %, a 48.1% increase from 2019.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -487 -213 -77.9% Jan 1, 2022 Dec 31, 2022
2021 -274 +12.2 +4.28% Jan 1, 2021 Dec 31, 2021
2020 -286 +265 +48.1% Jan 1, 2020 Dec 31, 2020
2019 -551 -463 -530% Jan 1, 2019 Dec 31, 2019
2018 -87.4 -95.2 -1218% Jan 1, 2018 Dec 31, 2018
2017 7.82 +69.3 Jan 1, 2017 Dec 31, 2017
2016 -61.5 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.